A Comprehensive Report for decision making

Drug Developer's Intelligence Report

Oncology Intelligence

2014

This Report is only Available on request...

Kindly Check the Latest Updated Volume of this Report​

RELEASED - JANUARY 2014

931

Oncology Drug Developers

This report contains enough data to make strategic decisions especially for new entrants.

- Dr. Mitsuyoshi Nishizaki

Second Updated Edition - oncology intelligence 2014 Report

Report to Cover all Aspects of Cancer Drug Development Intelligence

COMPANIES * MOLECULES * INDICATIONS * TECHNOLOGIES * DEALS * FUNDING

OI 2014 Vs OI 2013
(in terms of Oncology Drug Developers Number)

UPDATED DATA for
ACCURATE DECISIONS

 

OI 2014 is a key update over previous report OI 2013, as it may covers 398 more oncology drug developers than the previous report. It also abandoned 91 companies, which were earlier covered in OI 2013, which were either acquired/merged or closed during the period.

largest coverage

providing intelligence at fingertips

1
Countries

Largest Coverage with 33 Countries covered Globally

1
Drug developers

523 Clinical, 360 Preclinical & 48 Discovery Companies Profiles

1
Molecules

Individual Drug Mechanism of Action & Drug Target

1
Cancer Targets

Emerging Cancer Drug Targets Details

intelligence supercharged

1055 pages full of insights

Other Reports in this series

For Purchase, Kindly check the latest report available in this series...

Oncology Intelligence 2013
Comprehensive Decision Making Intelligence derived from Active 624 Oncology Drug Developers.
Oncology Intelligence 2014
Comprehensive Decision Making Intelligence derived from Active 931 Oncology Drug Developers.
Oncology Intelligence 2017
Comprehensive Decision Making Intelligence derived from Active 1047 Oncology Drug Developers.
Oncology Intelligence 2020
Upcoming Comprehensive Decision Making Report derived from Active 1250+ Oncology Drug Developers.
January 2013
March 2014
January 2017
Feburary 2020